Skip to main content
Pharma Mar S.A. logo

Pharma Mar S.A. — Investor Relations & Filings

Ticker · PHM ISIN · ES0169501022 LEI · 959800QWKZ45ZQC2AV58 MC Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2024-09-23 Transaction in Own Shar…
Country ES Spain
Listing MC PHM

About Pharma Mar S.A.

https://pharmamar.com/en/

Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.

Recent filings

Filing Released Lang Actions
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 16 de septiembre y el 20 de septiembre de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication addressed to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission). The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information) and the subject is 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock). It details specific 'Compra' (Buy) transactions of the company's own shares ('autocartera') over a defined period (Sept 16 to Sept 20, 2024). This directly corresponds to the definition of reporting transactions in own shares, which maps to the 'Transaction in Own Shares' category (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it an announcement of a report (RPA) as it contains the substantive data itself.
2024-09-23 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 9 de septiembre y el 13 de septiembre de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated September 16, 2024. The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information) and the subject is 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock). It details transactions made under a previously announced Share Repurchase Program during the period of September 9 to September 13, 2024. This explicitly describes the company buying back its own shares, which directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing, POS is the more specific category for share repurchase activity reports.
2024-09-16 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 2 de septiembre y el 6 de septiembre de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated September 9, 2024. The title is 'COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE' (Communication of Other Relevant Information) and the subject is 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock). It details transactions made under a previously announced share repurchase program ('Programa de Recompra') during the period of September 2 to September 6, 2024, including tables listing the number of shares bought and the average price. This directly corresponds to the definition of reporting the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS).
2024-09-09 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 26 de agosto y el 30 de agosto de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'Comisión Nacional del Mercado de Valores' (Spanish Securities Market Commission) dated September 2, 2024. The subject is the 'Programas de recompra de acciones, estabilización y autocartera' (Share repurchase programs, stabilization, and treasury stock) and details transactions conducted between August 26 and August 30, 2024. This explicitly reports on the company buying back its own shares as part of a previously announced program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it details a repurchase program, the core content is the transaction report itself, not just an announcement of the program's existence (which would be CAP or RPA).
2024-09-02 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 19 de agosto y el 23 de agosto de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication addressed to the Spanish National Securities Market Commission (Comisión Nacional del Mercado de Valores - CNMV). It explicitly references regulations concerning share repurchase programs ('Programas de recompra de acciones') and provides a detailed table showing transactions (purchases) made by the company (Pharma Mar, S.A.) on its own stock during a specific period (August 19 to August 23, 2024). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). Therefore, the appropriate code is POS.
2024-08-26 Spanish
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa de Recompra de Acciones en el periodo transcurrido entre el 12 de agosto y el 16 de agosto de 2024.
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the Spanish National Securities Market Commission ("Comisión Nacional del Mercado de Valores") dated August 19, 2024. The subject is "COMUNICACIÓN DE OTRA INFORMACIÓN RELEVANTE" (Communication of Other Relevant Information) specifically detailing transactions under a previously announced share repurchase program ("Programa de Recompra"). The core content is a table listing the dates, number of shares bought, and price for transactions conducted between August 12 and August 16, 2024. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is a regulatory filing, POS is the most specific category available for share repurchase activity reports.
2024-08-19 Spanish

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.